A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia

NCT05260411 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

246

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

BIOLOGICAL: AK102
BIOLOGICAL: AK102
DRUG: Placebo

Sponsor

Akeso